ONTOLOGY REPORT - ANNOTATIONS
| Term: | (+)-trans-(S)-allethrin |
|
| Accession: | CHEBI:39115
|
browse the term
|
| Definition: | A (+)-trans-allethrin that has formula C19H26O3. |
| Synonyms: | exact_synonym: | (1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)cyclopent-2-en-1-yl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate |
| | related_synonym: | (1S)-3-allyl-2-methyl-4-oxocyclopent-2-en-1-yl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; (S)-3-allyl-3-methyl-4-oxocyclopent-2-enyl (+)-trans-chrysanthemate; C19H26O3; CC(C)=C[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(CC=C)=C2C)C1(C)C; InChI=1S/C19H26O3/c1-7-8-13-12(4)16(10-15(13)20)22-18(21)17-14(9-11(2)3)19(17,5)6/h7,9,14,16-17H,1,8,10H2,2-6H3/t14-,16+,17+/m1/s1; InChIKey=ZCVAOQKBXKSDMS-PVAVHDDUSA-N; S-bioallethrin; bioallethrin S-cyclopentenyl; bioallethrin S-cyclopentenyl isomer; trans-(+)-allethrin |
| | xref_casrn: | 28434-00-6 |
| | xref: | ChEMBL:1327921 "ChEMBL COMPOUND"; ChemIDplus:2059862 "Beilstein Registry Number"; ChemIDplus:28434-00-6 "CAS Registry Number" |
| | xref_mesh: | MESH:C018465 |
| | cyclic_relationship: | is_enantiomer_of CHEBI:39121 |
|
|
(+)-trans-(S)-allethrin
|
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
multiple interactions |
ISO |
3 |
76,301,988 |
76,309,729 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
affects expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Scn10a |
sodium channel, voltage-gated, type X, alpha subunit |
|
affects activity |
EXP |
8 |
124,578,222 |
124,690,458 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
multiple interactions |
EXP |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Scn2b |
sodium channel, voltage-gated, type II, beta |
|
multiple interactions |
EXP |
8 |
48,068,843 |
48,078,632 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage gated, type VIII, alpha subunit |
|
multiple interactions |
EXP |
7 |
139,686,180 |
139,794,282 |
RGD:6480464 |
CTD |
Term paths to the root
|